Clinical Trials
The Phase 1a clinical trial of CV6-168 is ongoing across Northern Ireland and Great Britain. Dose escalation is continuing, and the study remains open to recruitment.
For information on current and future clinical studies, please consult your physician.
Trial Name
CV6-168
A first-in-human study to investigate the safety and tolerability of CV6-168 in combination with anti-cancer treatments in patients with advanced cancer.
Status
Active
phase
Phase 1a
Discovery
Preclinical
Phase 1a
Phase 1b
Disclaimer: CV6-168 and CV6-1271 are investigational therapies that have not been approved for use outside clinical studies by the MHRA, FDA, or other regulatory authorities.
“”
